Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Surgical Innovations ( (GB:SUN) ).
Surgical Innovations Group plc reported a profitable second half of 2024, indicating a successful turnaround attributed to effective cost management and restructuring efforts. The company anticipates full-year revenues to align with market expectations and adjusted EBITDA to exceed them slightly. Additionally, the company announced the appointment of Brent Greetham as the new Chief Financial Officer, bringing over 25 years of experience in the life sciences sector, which is expected to bolster the company’s growth trajectory.
More about Surgical Innovations
Surgical Innovations Group plc specializes in designing, manufacturing, and distributing innovative medical products primarily for minimally invasive surgery. The company offers port access systems, surgical instruments, and retraction devices, which are sold in the UK and globally. Their products focus on the ‘resposable’ concept, providing high-quality and environmentally responsible solutions that are cost-competitive against fully disposable alternatives. Surgical Innovations also collaborates with OEM partners and industrial partners for precision engineering solutions.
Average Trading Volume: 463,533
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £5.13M
For detailed information about SUN stock, go to TipRanks’ Stock Analysis page.